8-Hydroxyquinolines in medicinal chemistry: A structural perspective

V Oliveri, G Vecchio - European journal of medicinal chemistry, 2016 - Elsevier
Hydroxyquinolines are heterocyclic compounds characterized by a moderate metal-binding
affinity. The interest in 8-hydroxyquinolines has grown exponentially in the last two decades …

Metals and metal compounds in cancer treatment

B Desoize - Anticancer Research, 2004 - ar.iiarjournals.org
Metals and metal compounds have been used in medicine for several thousands of years. In
this review we summarized the anti-cancer activities of the ten most active metals: arsenic …

Novel di-2-pyridyl–derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment

J Yuan, DB Lovejoy, DR Richardson - Blood, 2004 - ashpublications.org
Aroylhydrazone and thiosemicarbazone iron (Fe) chelators have potent antitumor activity.
The aim of the current study was to examine the antitumor effects and mechanisms of action …

Synthetic and natural iron chelators: therapeutic potential and clinical use

HC Hatcher, RN Singh, FM Torti… - Future medicinal …, 2009 - Taylor & Francis
Iron-chelation therapy has its origins in the treatment of iron-overload syndromes. For many
years, the standard for this purpose has been deferoxamine. Recently, considerable …

Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor …

PJ Jansson, PC Sharpe, PV Bernhardt… - Journal of medicinal …, 2010 - ACS Publications
The novel chelators 2-acetylpyridine-4, 4-dimethyl-3-thiosemicarbazone (H Ap44mT) and di-
2-pyridylketone-4, 4-dimethyl-3-thiosemicarbazone (H Dp44mT) have been examined to …

Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and …

NTV Le, DR Richardson - Blood, 2004 - ashpublications.org
Iron (Fe) is critical for proliferation, but its precise role in cell cycle progression remains
unclear. In this study, we examined the mechanisms involved by assessing the effects of Fe …

Novel chelators for cancer treatment: where are we now?

AM Merlot, DS Kalinowski… - Antioxidants & redox …, 2013 - liebertpub.com
Significance: Under normal circumstances, cellular iron levels are tightly regulated due to
the potential toxic effects of this metal ion. There is evidence that tumors possess altered iron …

[HTML][HTML] Targeting cancer by binding iron: Dissecting cellular signaling pathways

GYL Lui, Z Kovacevic, V Richardson, AM Merlot… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Newer and more potent therapies are urgently needed to effectively treat advanced cancers
that have developed resistance and metastasized. One such strategy is to target cancer cell …

The role of iron chelation in cancer therapy

JL Buss, FM Torti, SV Torti - Current medicinal chemistry, 2003 - ingentaconnect.com
This review focuses on advances and strategies in the use of iron chelators as anti-tumor
therapies. Although the development of iron chelators for human disease has focused …

Tuning cell cycle regulation with an iron key

Y Yu, Z Kovacevic, DR Richardson - Cell cycle, 2007 - Taylor & Francis
Iron (Fe) is essential for cellular metabolism eg, DNA synthesis and its depletion causes
G1/S arrest and apoptosis. Considering this, Fe chelators have been shown to be effective …